367 related articles for article (PubMed ID: 25798839)
21. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase.
LaBranche H; Dupuis S; Ben-David Y; Bani MR; Wellinger RJ; Chabot B
Nat Genet; 1998 Jun; 19(2):199-202. PubMed ID: 9620782
[TBL] [Abstract][Full Text] [Related]
22. Involvement of retrotransposon L1 in stemness and cellular plasticity.
Apostolou P; Toloudi M; Chatziioannou M; Kourtidou E; Mimikakou G; Vlachou I; Chlichlia A; Papasotiriou I
Cell Commun Adhes; 2015; 22(1):1-7. PubMed ID: 25327441
[TBL] [Abstract][Full Text] [Related]
23. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
24. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
[TBL] [Abstract][Full Text] [Related]
25. [Progress on telomere and telomerase].
Yang X; Tao M
Wei Sheng Yan Jiu; 2004 May; 33(3):369-71. PubMed ID: 15211818
[TBL] [Abstract][Full Text] [Related]
26. Similarities between long interspersed element-1 (LINE-1) reverse transcriptase and telomerase.
Kopera HC; Moldovan JB; Morrish TA; Garcia-Perez JL; Moran JV
Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20345-50. PubMed ID: 21940498
[TBL] [Abstract][Full Text] [Related]
27. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
[TBL] [Abstract][Full Text] [Related]
28. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
29. [Molecular mechanisms involved in the regulation of telomerase activity].
Liu WJ; Ding J
Sheng Li Ke Xue Jin Zhan; 2001 Jul; 32(3):220-4. PubMed ID: 12545793
[TBL] [Abstract][Full Text] [Related]
30. An intact putative mouse telomerase essential N-terminal domain is necessary for proper telomere maintenance.
Rousseau P; Khondaker S; Zhu S; Lauzon C; Mai S; Autexier C
Biol Cell; 2016 Apr; 108(4):96-112. PubMed ID: 26787169
[TBL] [Abstract][Full Text] [Related]
31. Telomere dynamics and homeostasis in a transmissible cancer.
Ujvari B; Pearse AM; Taylor R; Pyecroft S; Flanagan C; Gombert S; Papenfuss AT; Madsen T; Belov K
PLoS One; 2012; 7(8):e44085. PubMed ID: 22952882
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts.
Swiggers SJ; Nibbeling HA; Zeilemaker A; Kuijpers MA; Mattern KA; Zijlmans JM
Exp Cell Res; 2004 Jul; 297(2):434-43. PubMed ID: 15212946
[TBL] [Abstract][Full Text] [Related]
33. Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor.
Incles CM; Schultes CM; Kelland LR; Neidle S
Mol Pharmacol; 2003 Nov; 64(5):1101-8. PubMed ID: 14573759
[TBL] [Abstract][Full Text] [Related]
34. Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase.
Zhu S; Rousseau P; Lauzon C; Gandin V; Topisirovic I; Autexier C
Biochimie; 2014 Jun; 101():93-103. PubMed ID: 24412622
[TBL] [Abstract][Full Text] [Related]
35. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
[TBL] [Abstract][Full Text] [Related]
36. Telomerase-independent stabilization of short telomeres in Trypanosoma brucei.
Dreesen O; Cross GA
Mol Cell Biol; 2006 Jul; 26(13):4911-9. PubMed ID: 16782879
[TBL] [Abstract][Full Text] [Related]
37. Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development.
Waki K; Anno K; Ono T; Ide T; Chayama K; Tahara H
Cancer Sci; 2010 Jul; 101(7):1678-85. PubMed ID: 20456367
[TBL] [Abstract][Full Text] [Related]
38. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).
El Daly H; Martens UM
Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817
[TBL] [Abstract][Full Text] [Related]
39. Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells.
Zhang B; Bai YX; Ma HH; Feng F; Jin R; Wang ZL; Lin J; Sun SP; Yang P; Wang XX; Huang PT; Huang CF; Peng Y; Chen YC; Kung HF; Huang JJ
Cancer Res; 2009 Jan; 69(1):75-83. PubMed ID: 19117989
[TBL] [Abstract][Full Text] [Related]
40. Telomeres and telomerase dance to the rhythm of the cell cycle.
Londoño-Vallejo JA; Wellinger RJ
Trends Biochem Sci; 2012 Sep; 37(9):391-9. PubMed ID: 22727244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
